Catalyst Wire Dossier Catalyst Wire Dossier

D-CIK Immunotherapy

D-CIK immunotherapy (dendritic cell and cytokine-induced killer cells)
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for D-CIK Immunotherapy, covering 2016-09-01 to 2018-11-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal Carcinoma [Phase 2]

See pricing